ICARES Medicus, Inc. (TPEX:6612)
88.60
-2.40 (-2.64%)
Oct 31, 2025, 2:31 PM CST
ICARES Medicus Revenue
ICARES Medicus had revenue of 269.20M TWD in the quarter ending June 30, 2025, with 45.56% growth. This brings the company's revenue in the last twelve months to 1.08B, up 67.55% year-over-year. In the year 2024, ICARES Medicus had annual revenue of 859.79M with 42.01% growth.
Revenue (ttm)
1.08B
Revenue Growth
+67.55%
P/S Ratio
3.84
Revenue / Employee
n/a
Employees
64
Market Cap
4.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 859.79M | 254.34M | 42.01% |
| Dec 31, 2023 | 605.45M | 93.60M | 18.29% |
| Dec 31, 2022 | 511.85M | 117.93M | 29.94% |
| Dec 31, 2021 | 393.92M | 31.25M | 8.62% |
| Dec 31, 2020 | 362.67M | -56.70M | -13.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.90B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Caliway Biopharmaceuticals | 44.83M |